Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Report on sedar

<< Previous

Bullboard Posts

Next >>

Comment by Infinityon Nov 26, 2024 1:30pm

102 Views

Post# 36331656

RE:RE:RE:RE:RE:RE:RE:Report on sedar

Yes they have worked no question there. They CEO, CFO and Chief scientific officer have all been very reasonably compensated for the last 15 years for a company that generaties no revenue. To Reward yourself while the share holder values have not even kept up with the inflation rate seems excessive to me. However I respect your views.

<< Previous

Bullboard Posts

Next >>

Options trading in a volatile macro environment